Clinical Trial Update: Rucaparib vs Placebo Maintenance Therapy in Metastatic and Recurrent Endometrial Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating maintenance Rucaparib versus placebo in metastatic or recurrent endometrial cancer with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• Rucaparib (rucaparib)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Metastatic Endometrial Cancer | Phase 2 | Status: COMPLETED | Results posted: 2024-07-01